PKA anticorps (Catalytic Subunit)

N° du produit ABIN7075244

Cet anticorps Lapin Polyclonal détecte spécifiquement PKA dans WB. Il présente une réactivité envers Humain, Souris et Rat.

Aperçu rapide pour PKA anticorps (Catalytic Subunit) (ABIN7075244)

Antigène: PKA (Protein Kinase A (PKA))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PKA est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-PKA anticorps

Épitope: Catalytic Subunit

Réactivité croisée: Humain, Rat

Purification: Affinity purification

Immunogène: Recombinant protein corresponding to Mouse PKA alpha+beta

Information d'application

Indications d'application: WB (H,M,R) 1: 500-1: 1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, pH 7.4, 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Détails sur PKA

Antigène: PKA (Protein Kinase A (PKA))

Autre désignation: PKA alpha+beta

Sujet: The catalytic subunit α of protein kinase A is a key regulatory enzyme that in humans is encoded by the PRKACA gene. This enzyme is responsible for phosphorylating other proteins and substrates, changing their activity. Protein kinase A catalytic subunit (PKA Cα) is a member of the AGC kinase family (protein kinases A, G, and C), and contributes to the control of cellular processes that include glucose metabolism, cell division, and contextual memory. PKA Cα is part of a larger protein complex that is responsible for controlling when and where proteins are phosphorylated. Defective regulation of PKA holoenzyme activity has been linked to the progression of cardiovascular disease, certain endocrine disorders and cancers.

Poids moléculaire: 41 kDa

ID gène: 18747

NCBI Accession: NP_001264827

UniProt: P05132

Pathways: SARS-CoV-2 Protein Interactome